SACC Houston: Houston Live is asking "What is the way forward for vaccine and m-RNA post Covid?"

Virus and Vaccine manufacturing the future of Biotech and Contract Development and Manufacturing Organizations / CDMO’s - what is the way forward for vaccine and m-RNA post Covid?

Join us for another installment of Houston Live, a biweekly web series airing every other Wednesday at 11 am CST. In this series, hear from Michael L. Stewart, MS and Chief Technical Officer at Matica Biotechnology Inc., and a presentation by Christopher Westerlund, Head of Finance at Matica. The event will be presented and moderated by André Persson, Chairman of the Board for SACC Houston.

About Michael L. Stewart

Michael L. Stewart has over 16 years of experience in the viral vector and vaccine production industry. Mike leads Matica Bio’s technical functions including Process Engineering, Process Development and Assay Development. Prior to joining Matica Bio, Mike was the Director of Manufacturing for Fujifilm Diosynth Biotechnologies, a CDMO providing manufacturing services to clients for virus-based vaccines products.

In addition to his three years at Fujifilm, Mike has worked for protein and virus organizations including Boehringer-Ingelheim Biomanufacturing, Meridian LifeScience, and St. Jude’s Children's Research Hospital (SJCRH).

Prior to his time in the industry, Mike completed Ph.D. Biochemistry studies at the University of Tennessee and St. Jude Children's Research Hospital focusing on the structural and functional amino acid substitutions that result in an oncogenic state. Mike served as a Medical Corpsman with the U.S. Navy / Marine Corps researching gravitational induced (rapid and gradual onset) loss of consciousness under Major General J.E. Whinnery, PhD, M.D. (retd.). Mike received his BS and MS degrees in Chemistry and Biochemistry from the Texas A&M University System.

About Christopher Westerlund

Christopher Westerlund is Head of Finance at Matica Biotech and is an executive with proven leadership in multiple public, fortune 500, private and private equity companies.

He has experience from strategic planning, forecasting, ROFO, yearly plan, 10+ years of FP&A management of $50M to $1.5 B. He has lead implementations, process improvements including Lean Six Sigma and cross functional projects leadership, as well as financial strategy, profit improvement plans, business cycle, startup and business crisis management. Christopher has 15+ years of experience in the U.S.,Latin America, Europe and the Middle East, and holds a Masters in Finance.

Set a reminder or join us directly on Zoom on Wednesday, October 20 at 11am CT,
https://us02web.zoom.us/j/83098607473?pwd=WTRER3ZsaU1NOC9jM3dVQSs3d3RXUT09

Images

Enter your email address below to receive a reminder message.

Please complete the Captcha

Date and Time

Wednesday Oct 20, 2021
11:00 AM - 12:00 PM CDT

Location

Join us directly on Zoom on Wednesday, October 20 at 11am CT,
https://us02web.zoom.us/j/83098607473?pwd=WTRER3ZsaU1NOC9jM3dVQSs3d3RXUT09

Fees/Admission

This event is free to attend for members and non-members. Recordings of past Houston Live sessions are only available to members. We encourage interested non-members to consider purchasing a SACC TX membership in order to receive access to these recordings and other exclusive event content. For more information about the benefits of becoming a SACC member, click here.

If you are a SACC member and would like to access recordings of past Houston Live sessions, please email houston@sacctx.com with your membership information to receive the password necessary for accessing the members-only video page on our website.

Contact Information

Andre Persson, SACC-Houston Chairman
Send Email